Prognostic Significance of Germline DICER1 Pathogenic or Likely Pathogenic Variants in Outcomes of Ovarian Sertoli-Leydig Cell Tumor

生殖系 医学 内科学 肿瘤科 妇科 癌症研究 生物 遗传学 基因
作者
Alexander T. Nelson,David Watson,Kenneth Chen,Damon R. Olson,Jennifer N. Stall,Kyle M. Devins,Robert H. Young,Junne Kamihara,Paige Mallinger,Jung Kim,Jessica N. Hatton,Yoav H. Messinger,A. Lindsay Frazier,Douglas R. Stewart,Dominik T. Schneider,Anne K. Harris,Louis P. Dehner,D. Ashley Hill,Kris Ann P. Schultz
出处
期刊:JCO precision oncology [Lippincott Williams & Wilkins]
卷期号: (9) 被引量:2
标识
DOI:10.1200/po-24-00902
摘要

PURPOSE Sertoli-Leydig cell tumors (SLCTs) are rare sex cord-stromal tumors, representing <0.5% of all ovarian tumors. We analyze the role of germline DICER1 status in outcomes of ovarian SLCT. METHODS Patients with SLCT were enrolled in the International Pleuropulmonary Blastoma/ DICER1 Registry and/or the International Ovarian and Testicular Stromal Tumor Registry. Medical records were systematically abstracted, and those with known germline DICER1 status were selected for analysis. RESULTS Of 162 patients with SLCT, 60% had a germline DICER1 pathogenic or likely pathogenic (P/LP) variant. The adjusted 3-year recurrence-free survival (RFS) was 87.2% (95% CI, 79.4 to 95.8) for patients with a germline DICER1 P/LP variant compared with 78.1% (95% CI, 66.4 to 91.9) for those without a germline DICER1 P/LP variant ( P = .043). The adjusted 3-year and 5-year overall survival (OS) was 93.9% (95% CI, 87.3 to 100.0) for those with a germline DICER1 P/LP variant compared with the 3-year OS of 91.3% (95% CI, 83.4 to 100.0) and the 5-year OS of 78.2% (95% CI, 63.8 to 95.9) for those without a germline DICER1 P/LP variant ( P = .021). Among patients with a germline DICER1 P/LP variant, the risk of a subsequent, nonrecurrent event was 36.2% (95% CI, 21.4 to 48.1) within 10 years. Previous/concurrent and subsequent neoplasms were rare among those without a germline DICER1 P/LP variant. CONCLUSION This cohort study of patients with SLCT demonstrated that those with germline DICER1 P/LP variants had superior RFS and OS even when adjusting for other prognostic factors. Beyond prognostic implications of a germline DICER1 P/LP variant, germline testing helps identify patients at risk of subsequent neoplasms, including metachronous SLCT.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
AKTAO发布了新的文献求助10
1秒前
wwwww发布了新的文献求助20
2秒前
2秒前
Echo发布了新的文献求助10
2秒前
3秒前
lizh187完成签到 ,获得积分10
4秒前
JasonChan完成签到 ,获得积分10
4秒前
4秒前
Jasper的应助被oo采纳,获得30
5秒前
英姑的应助被辰侑依采纳,获得10
5秒前
我我发布了新的文献求助10
5秒前
5秒前
6秒前
天天发布了新的文献求助10
6秒前
Owen的应助被温凛采纳,获得10
6秒前
强强发布了新的文献求助10
7秒前
7秒前
7秒前
袁rrrr完成签到,获得积分10
7秒前
ww完成签到,获得积分10
7秒前
7秒前
AAA麻精批发完成签到,获得积分10
8秒前
9秒前
巴拉巴拉发布了新的文献求助10
10秒前
111发布了新的文献求助30
10秒前
10秒前
悦耳的城发布了新的文献求助10
11秒前
花青素ii发布了新的文献求助10
11秒前
英姑的应助被李峥采纳,获得10
12秒前
kychao完成签到,获得积分10
13秒前
liugm发布了新的文献求助10
13秒前
13秒前
幻文悠发布了新的文献求助10
13秒前
英俊的铭的应助被快乐的忆安采纳,获得20
13秒前
找回自己发布了新的文献求助10
14秒前
14秒前
科研通AI2S的应助被yxxxxx采纳,获得10
15秒前
秋风的应助被仁爱的沁采纳,获得100
15秒前
斯文败类的应助被我我采纳,获得30
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193684
求助须知:如何正确求助?哪些是违规求助? 9579855
关于积分的说明 21867890
捐赠科研通 7793357
什么是DOI,文献DOI怎么找? 3437385
关于科研通互助平台的介绍 2560783
邀请新用户注册赠送积分活动 2484193